MTOR and central nervous system cancer: What’s more, ibrutinib is a promising therapeutic strategy for glioma, blocking the glioma cell proliferation, migration, and invasion properties and inducing glioma cell apoptosis and autophagy, targeting the Akt/mTOR pathway (53).